V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10006558 | 10007264 | 1.76 | 60.8 | Palliative (P) | 2017-11-19 | 2017-12-03 | Temozolomide 150mg/m2 | N | N | 10437398 | TEMOZOLOMIDE |
| 10006559 | 10004383 | 1.8 | 10 | Palliative (P) | 2017-04-17 | 2017-04-17 | Fluorouricil + Folonic Acid (MdG) | N | N | 10437409 | LENALIDOMIDE |
| 10006560 | 10007265 | 1.66 | 0 | Palliative (P) | 2016-08-26 | 2016-08-27 | Bevacizumab 7.5mg/kg | N | N | 10437468 | NOT MATCHED |
| 10006561 | 10004386 | 1.57 | 55 | Not known (9) | 2017-06-06 | 2017-09-28 | Carboplatin + Etoposide IV 3 day | N | N | 10437478 | CARBOPLATIN + ETOPOSIDE |
| 10006562 | 10007266 | 1.61 | 64 | Palliative (P) | null | 2015-12-18 | GEMCARBO | N | N | 10437559 | CARBOPLATIN |
| 10006563 | 10007266 | 1.71 | null | Disease modification (D) | 2019-02-21 | 2019-02-26 | Trial Unspecified | N | N | 10437559 | TRIAL |
| 10006564 | 10004387 | 1.79 | 78.4 | Adjuvant (A) | 2018-12-07 | 2018-12-07 | Capecitabine | N | N | 10437758 | CAPECITABINE |
| 10006565 | 10004388 | 1.69 | 127 | Palliative (P) | 2018-06-02 | 2018-06-02 | Pemetrexed | 02 | N | 10437936 | ABIRATERONE |
| 10006566 | 10004389 | null | 66.3 | Palliative (P) | null | 2015-05-19 | Temozolomide 200mg/m2 | N | N | 10438015 | TEMOZOLOMIDE |
| 10006567 | 10004390 | 1.72 | 70.6 | Palliative (P) | 2016-04-29 | 2016-05-09 | Carboplatin + Etoposide iv&po | null | null | 10438293 | CARBOPLATIN + ETOPOSIDE |
| 10006568 | 10004391 | 1.74 | 84 | Disease modification (D) | 2015-04-25 | 2015-05-08 | GEMCARBO | 1 | N | 10438293 | FLUOROURACIL |
| 10006569 | 10008955 | 1.83 | 57 | c | 2016-10-29 | 2017-04-10 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 10438409 | NOT MATCHED |
| 10006570 | 10004393 | 0 | 84 | Palliative (P) | 2016-08-24 | 2016-09-07 | GemCarbo Days 1+8 | 02 | N | 10438513 | CARBOPLATIN + PEMETREXED |
| 10006571 | 10004394 | 1.74 | 89.6 | Palliative (P) | 2018-10-17 | 2018-10-17 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 2 | Y | 10438631 | IBRUTINIB |
| 10006572 | 10004398 | null | 73.2 | Neo-adjuvant (N) | 2016-07-27 | 2016-07-31 | BCG Intravesical | N | N | 10438843 | CTD |
| 10006573 | 10004399 | 1.65 | 71.2 | Palliative (P) | 2016-06-22 | 2016-06-22 | Azacitidine | 02 | N | 10439112 | AZACITIDINE |
| 10006574 | 10004401 | 1.81 | 87.2 | Palliative (P) | 2018-01-06 | 2018-01-07 | Carboplatin + Pemetrexed | 2 | N | 10439385 | LENALIDOMIDE |
| 10006578 | 10009169 | 1.77 | 50.2 | Curative (C) | 2015-09-02 | 2015-09-05 | IBRUTINIB | 02 | N | 10439632 | GEMCARBO |
| 10006579 | 10009169 | 1.73 | null | Palliative (P) | 2016-12-26 | 2017-02-21 | Pemetrexed | 02 | N | 10439632 | ABIRATERONE |
| 10006580 | 10004404 | 1.6 | 59.3 | Palliative (P) | 2018-04-27 | 2018-05-19 | Carboplatin + Pemetrexed | N | N | 10439721 | CARBOPLATIN + VINORELBINE |
| 10006581 | 10004405 | 1.7 | null | Palliative (P) | null | 2018-06-10 | Trial Unspecified | 2 | null | 10439731 | TRIAL |
| 10006582 | 10004407 | 1.67 | 73 | Adjuvant (A) | 2014-12-02 | 2015-06-17 | Abiraterone | 02 | null | 10439849 | BCG |
| 10006583 | 10004408 | 1.73 | 70.2 | Adjuvant (A) | 2018-01-16 | 2018-05-10 | IBRUTINIB | N | null | 10439881 | GEMCARBO |
| 10006584 | 10004409 | 1.77 | null | Neo-adjuvant (N) | 2017-11-01 | 2017-11-01 | BCG Intravesical | 2 | N | 10439905 | NOT MATCHED |
| 10006585 | 10004412 | 1.68 | 58.6 | Disease modification (D) | 2016-06-12 | 2016-06-20 | Trial Unspecified | N | N | 10440004 | TRIAL |
| 10006586 | 10004414 | 1.66 | 114.5 | Palliative (P) | 2016-07-02 | 2016-07-02 | LENALIDOMIDE | N | null | 10440166 | FLUOROURACIL |
| 10006587 | 10004416 | 1.68 | 84 | Disease modification (D) | 2016-02-25 | 2016-03-02 | GemCarbo Days 1+8 | 01 | N | 10440290 | GEMCITABINE |
| 10006588 | 10004417 | 1.71 | 88.4 | Curative (C) | 2018-06-20 | 2018-06-22 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 10440402 | GEMCARBO |
| 10006589 | 10004419 | 1.8 | 84.9 | Palliative (P) | 2015-11-25 | 2015-12-14 | CARBOPLATIN + ETOPOSIDE | 2 | N | 10440415 | CARBOPLATIN + ETOPOSIDE |
| 10006590 | 10007273 | 1.71 | 75.8 | null | 2015-07-24 | 2015-10-02 | null | N | N | 10440576 | GEMCARBO |
| 10006591 | 10004422 | 1.58 | 92.85 | Palliative (P) | 2017-08-17 | 2017-08-20 | CARBOPLATIN + ETOPOSIDE | 02 | N | 10440602 | CARBOPLATIN + ETOPOSIDE |
| 10006592 | 10004423 | 1.76 | 72.7 | Palliative (P) | 2016-12-03 | 2016-12-30 | Carboplatin AUC 2 - 5 | 02 | N | 10440616 | GEMCITABINE |
| 10006593 | 10004424 | null | 58 | Palliative (P) | 2018-09-09 | 2018-11-21 | Carboplatin + Pemetrexed | N | N | 10440700 | BEVACIZUMAB |
| 10006594 | 10004425 | null | 87.3 | Palliative (P) | 2018-01-31 | 2018-02-09 | Capecitabine | 2 | Y | 10440735 | CAPECITABINE |
| 10006595 | 10008474 | 1.78 | 0 | Adjuvant (A) | 2014-02-28 | 2014-03-02 | Carboplatin + Paclitaxel (3 weekly) | N | N | 10440735 | CARBOPLATIN + PACLITAXEL |
| 10006596 | 10004427 | 1.75 | 109 | Palliative (P) | 2018-06-08 | 2018-06-22 | Trial Unspecified | 02 | N | 10441160 | TRIAL |
| 10006597 | 10004428 | 1.65 | 70.6 | Adjuvant (A) | 2017-06-08 | 2017-06-14 | CARBOPLATIN + PACLITAXEL | null | Y | 10441282 | CARBOPLATIN + PACLITAXEL |
| 10006598 | 10007276 | 1.64 | 65 | Palliative (P) | 2018-08-14 | 2019-03-19 | CTD | 02 | N | 10441373 | PEMETREXED |
| 10006599 | 10004429 | 1.55 | 49.9 | Palliative (P) | 2016-04-22 | 2016-04-28 | Carboplatin 21day + Paclitaxel 7day | 02 | N | 10441399 | CARBOPLATIN + PACLITAXEL |
| 10006600 | 10004430 | 1.55 | 55.6 | Palliative (P) | 2015-09-22 | 2015-09-23 | GemCarbo Days 1+8 | N | N | 10441542 | ABIRATERONE |
| 10006601 | 10004431 | 1.87 | 90.6 | Curative (C) | 2019-04-08 | 2019-04-08 | Carboplatin + Etoposide IV 3 day | N | N | 10441542 | CARBOPLATIN + ETOPOSIDE |
| 10006602 | 10004431 | 1.54 | 64 | Curative (C) | 2018-10-26 | 2019-05-16 | Bendamustine+Rituximab(Sub Courses) | N | N | 10441542 | BENDAMUSTINE + RITUXIMAB |
| 10006603 | 10004432 | 1.52 | 67.6 | Palliative (P) | 2018-04-13 | 2018-04-18 | BENDAMUSTINE + RITUXIMAB | 02 | N | 10442021 | BENDAMUSTINE + RITUXIMAB |
| 10006604 | 10004433 | 1.65 | 60.2 | Palliative (P) | 2017-11-12 | 2017-11-26 | Carboplatin + Pemetrexed | N | N | 10442212 | GEMCARBO |
| 10006605 | 10004433 | 1.79 | 66.4 | Palliative (P) | 2014-05-20 | 2014-06-05 | BCG Intravesical | N | N | 10442212 | CARBOPLATIN + VINORELBINE |
| 10006606 | 10004433 | 0 | 93.1 | Adjuvant (A) | 2018-02-12 | 2018-02-13 | Gemcitabine weekly | 2 | N | 10442212 | IBRUTINIB |
| 10006607 | 10004433 | 1.61 | 72 | Not known (9) | 2018-07-17 | 2018-07-17 | Trial Unspecified | 2 | N | 10442212 | TRIAL |
| 10006608 | 10004434 | 1.88 | null | null | 2018-09-15 | 2018-09-15 | Temozolomide 150mg/m2 | N | N | 10442560 | TEMOZOLOMIDE |
| 10006609 | 10004435 | 1.79 | null | null | 2014-11-19 | 2014-11-22 | Carboplatin + Etoposide iv&po | Y | N | 10442568 | CARBOPLATIN + ETOPOSIDE |
| 10006610 | 10004436 | 1.7 | null | Curative (C) | 2017-08-15 | 2017-08-15 | Azacitidine | N | N | 10442658 | AZACITIDINE |